Completed PHASE2 INTERVENTIONAL 2-arm NCT00312897

Omega-3 Fatty Acids in Adolescent Depression

Sponsor: Icahn School of Medicine at Mount Sinai

Interventions Omega-3 Fatty Acids corn oil

Updated 7 times since 2017 Last updated: Mar 20, 2018 Started: Dec 31, 2005 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Adolescent Depression and is currently completed. Icahn School of Medicine at Mount Sinai leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Mar 2018 — Jun 2018 [monthly]

Completed PHASE2

Phase: NA → PHASE2

▶ Show 2 earlier versions

Feb 2017 — Mar 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)

Data source: Icahn School of Medicine at Mount Sinai

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States